Pulmonary sarcoidosis treatment

aTyr Pharma’s Efzofitimod trial failed, dealing a major blow to the development of a drug for lung disease, and the company’s future progress depended on it.The world of pharmaceuticals and biotech has always been an area of ​​great hope and great risk. If a successful drug is developed, it can give a new life…